Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uvea--Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01314417
What this trial is testing

Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate

Who this might be right for
Non-infectious Intermediate and Posterior Uveitis
National Eye Institute (NEI) 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Post-approval studies (Phase 4)UnknownNCT05649111
What this trial is testing

The Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification

Who this might be right for
Uveitis, Anterior
Kafrelsheikh University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07547995
What this trial is testing

Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

Who this might be right for
Uveitis
Changchun GeneScience Pharmaceutical Co., Ltd. 74
Testing effectiveness (Phase 2)Study completedNCT02223819
What this trial is testing

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Who this might be right for
Uveal Melanoma
Columbia University 34
Large-scale testing (Phase 3)Study completedNCT04597632
What this trial is testing

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 248
Not applicableStudy completedNCT04376411
What this trial is testing

Role of Regulatory B Cells in Behçet's Disease

Who this might be right for
Behcet Disease
Assiut University 74
Not applicableUnknownNCT04976244
What this trial is testing

Brolucizumab for CNV Associated With Pathologic Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 50
Testing effectiveness (Phase 2)Study completedNCT05044598
What this trial is testing

RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy

Who this might be right for
Aniridia
University College, London 9
Not applicableStudy completedNCT01080898
What this trial is testing

Evaluation of Optical Coherence Tomography.

Who this might be right for
Age-Related Macular DegenerationChoroidal Vessels; Anastomosis
Assistance Publique - Hôpitaux de Paris 151
Not applicableStudy completedNCT03264391
What this trial is testing

Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography

Who this might be right for
Retinal VasculitisBehcet Syndrome
Assiut University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Large-scale testing (Phase 3)Study completedNCT02374060
What this trial is testing

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial

Who this might be right for
Macular EdemaUveitis
JHSPH Center for Clinical Trials 192
Early research (Phase 1)Study completedNCT00001735
What this trial is testing

Gene Therapy for Gyrate Atrophy

Who this might be right for
Gyrate Atrophy
National Eye Institute (NEI) 5
Not applicableStudy completedNCT01055717
What this trial is testing

Bioavailability of Avenanthramide-Enriched Oats in Healthy Older Adults

Who this might be right for
Healthy
Tufts University 12
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableLooking for participantsNCT05439161
What this trial is testing

XEN Glaucoma Gel Stent Versus Trabeculectomy

Who this might be right for
Primary Open Angle GlaucomaPseudoexfoliation GlaucomaPigmentary Dispersion Glaucoma
Prof. Dr. Herbert Reitsamer 196
Early research (Phase 1)Study completedNCT02768766
What this trial is testing

Intermittent Selumetinib for Uveal Melanoma

Who this might be right for
Uveal Melanoma
Shaheer A. Khan 42
Not applicableStudy completedNCT03963596
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 122
Not applicableUnknownNCT00931957
What this trial is testing

Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

Who this might be right for
Behcet SyndromeUveal Disease
Tehran University of Medical Sciences 80
Next Page